Twenty-five years of quantitative PCR for gene expression analysis HD VanGuilder, KE Vrana, WM Freeman Biotechniques 44 (5), 619-626, 2008 | 1761 | 2008 |
Quantitative RT-PCR: pitfalls and potential WM Freeman, SJ Walker, KE Vrana Biotechniques 26 (1), 112-125, 1999 | 1746 | 1999 |
Intricate regulation of tyrosine hydroxylase activity and gene expression SC Kumer, KE Vrana Journal of neurochemistry 67 (2), 443-462, 1996 | 901 | 1996 |
Cytotoxic and genotoxic potential of dopamine AH Stokes, TG Hastings, KE Vrana Journal of neuroscience research 55 (6), 659-665, 1999 | 590 | 1999 |
Parthenogenetic stem cells in nonhuman primates JB Cibelli, KA Grant, KB Chapman, K Cunniff, T Worst, HL Green, ... Science 295 (5556), 819-819, 2002 | 481 | 2002 |
Adenosine cyclic 3', 5'-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit PF Cook, ME Neville Jr, KE Vrana, FT Hartl, R Roskoski Jr Biochemistry 21 (23), 5794-5799, 1982 | 467 | 1982 |
Fundamentals of DNA hybridization arrays for gene expression analysis WM Freeman, DJ Robertson, KE Vrana Biotechniques 29 (5), 1042-1055, 2000 | 291 | 2000 |
Tyrosine mRNA is expressed in human substantia nigra Y Xu, AH Stokes, WM Freeman, SC Kumer, BA Vogt, KE Vrana Molecular Brain Research 45 (1), 159-162, 1997 | 262 | 1997 |
Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase Y Xu, AH Stokes, R Roskoski Jr, KE Vrana Journal of neuroscience research 54 (5), 691-697, 1998 | 260 | 1998 |
Nonhuman primate parthenogenetic stem cells KE Vrana, JD Hipp, AM Goss, BA McCool, DR Riddle, SJ Walker, ... Proceedings of the National Academy of Sciences 100 (suppl_1), 11911-11916, 2003 | 257 | 2003 |
Manganese uptake and distribution in the central nervous system (CNS). M Aschner, KE Vrana, W Zheng Neurotoxicology 20 (2-3), 173-180, 1999 | 233 | 1999 |
Mapping functional regions of transcription factor TFIIIA KE Vrana, MEA Churchill, TD Tullius, DD Brown Molecular and cellular biology, 1988 | 217 | 1988 |
Nitration and inactivation of tyrosine hydroxylase by peroxynitrite B Blanchard-Fillion, JM Souza, T Friel, GCT Jiang, K Vrana, V Sharov, ... Journal of Biological Chemistry 276 (49), 46017-46023, 2001 | 215 | 2001 |
Circulating cytokines as biomarkers of alcohol abuse and alcoholism RN Achur, WM Freeman, KE Vrana Journal of Neuroimmune Pharmacology 5, 83-91, 2010 | 214 | 2010 |
The pharmacological case for cannabigerol R Nachnani, WM Raup-Konsavage, KE Vrana Journal of Pharmacology and Experimental Therapeutics 376 (2), 204-212, 2021 | 167 | 2021 |
Complex molecular regulation of tyrosine hydroxylase I Tekin, R Roskoski, N Carkaci-Salli, KE Vrana Journal of neural transmission 121, 1451-1481, 2014 | 145 | 2014 |
Chronic cocaine‐mediated changes in non‐human primate nucleus accumbens gene expression WM Freeman, MA Nader, SH Nader, DJ Robertson, L Gioia, SM Mitchell, ... Journal of neurochemistry 77 (2), 542-549, 2001 | 144 | 2001 |
Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration WM Freeman, KM Patel, RM Brucklacher, ME Lull, M Erwin, D Morgan, ... Neuropsychopharmacology 33 (8), 1807-1817, 2008 | 143 | 2008 |
Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels SL Vrana, KE Vrana, TR Koves, JE Smith, SI Dworkin Journal of neurochemistry 61 (6), 2262-2268, 1993 | 139 | 1993 |
Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals CA Legare, WM Raup-Konsavage, KE Vrana Pharmacology 107 (3-4), 131-149, 2022 | 135 | 2022 |